Abstract 287P
Background
Yoga is one of the oldest therapies and has been practiced for millennia to promote physical and mental health. Yoga decreased cancer-related symptoms and treatment-related adverse effects, such as fatigue and nausea, and enhanced general well-being and quality of life. However, the duration of the yoga intervention in these investigations was a maximum of six months. In this study, the yoga intervention was given for one year.
Methods
The institutional ethics committee approved the study. This study enrolled a total of 96 patients after considering the inclusion and exclusion criteria, and they were randomly divided into two groups (non-yoga and yoga). Patients received training for the asanas Tadasna, Tiryaka Tadasana, Katichakrasana, Padadhirasana, Gomukhasana, Shavasana, Nadishodhan Pranayama, and Ujjayi Pranayama, which were performed for 45 minutes, five days per week, for the period of one year. We used the validated EORTC-QLQ30 and EORTC-BR23 questionnaires to assess the quality of life, symptomatic scale, fatigue, and functional scale in breast cancer patients. We calculated them at baseline, the fourth month, the eighth month, and the twelfth month, and compared them to the control group as well as with the intergroup.
Results
For each time point, 42 patients in the yoga group and 40 patients in the control group were analyzed. In the yoga group, two patients died and four were lost to follow-up and in non-yoga group, four patients died and four were lost to follow-up. At 4th(p<.05), 8th (p<0.01), and 12th month (p<0.001) post-baseline, the yoga group's quality of life improved significantly. In contrast, the non-yoga group shows substantial declines from baseline to the 4th(p<.05), 8th (p<0.01), and 12th month (p<0.001). The symptomatic and functional scales are also enhanced in the yoga group relative to the control group. The most significant difference from baseline was found in the functional scale at 12 months (p<0.05).
Conclusions
Long-term yoga intervention improved both their functional and symptomatic scales, as well as their quality of life. This suggests that yoga could be an effective complementary therapy for breast cancer patients undergoing treatment.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Ministry of Ayush, Government of India.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
281P - Cancer-related symptoms as mediators between treatment and functional capacity in adolescents and young adults (AYAs) with cancer
Presenter: Chung Tin Justin Ma
Session: Poster viewing 04
282P - Nutritional status and nutritional therapy of common cancer in a cancer hospital of Southwest China
Presenter: Huiqing Yu
Session: Poster viewing 04
283P - Comparative analysis of osteoporotic fracture (OF) and pathologic fracture (PF) in patients with metastatic colorectal cancer (mCRC) who received palliative chemotherapy
Presenter: Yejee Lim
Session: Poster viewing 04
284P - Gut microbiota mediates the protective effects of resveratrol against the intestinal barrier dysfunction in non-alcoholic steatohepatitis induced by high-fat diet
Presenter: Haoyang Cao
Session: Poster viewing 04
285P - Reticulocyte hemoglobin equivalent as an early predictor of iron deficiency anemia in cancer patients
Presenter: Aditya Sarin
Session: Poster viewing 04
286P - Breakthrough COVID-19 infections in patients with cancer from a prospective study of COVID-19 vaccine response
Presenter: Amy Body
Session: Poster viewing 04
288P - Impact of hormonal contraception on estradiol and progesterone serum levels: A 6-year study on progression-free survival, disease-free survival, and overall survival at Dr. Moewardi Hospital
Presenter: Widyanti Soewoto
Session: Poster viewing 04
289P - Cancer cachexia following breast cancer (BC) chemotherapy was associated with clinical stage, number of chemotherapy cycles, and vitamin D concentration
Presenter: Susanna Hutajulu
Session: Poster viewing 04
290P - Use of PEG G-CSF is associated with decreased myelotoxicity in dexrazoxane-used aggressive non-Hodgkin lymphoma patients
Presenter: Sung-Nam Lim
Session: Poster viewing 04
291P - Assessment of nutritional status in cancer patients using patient generated subjective global assessment screening tool
Presenter: Anuj K. C.
Session: Poster viewing 04